Dynamic Technology Lab’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Dynamic Technology Lab’s Portfolio TPTX Stock Details TPTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-9,815	Closed	-$652K	–	1626
2021 Q3	$652K	Buy	+9,815	New	+$699K	0.08%	431
2021 Q2	–	Sell	-5,543	Closed	-$524K	–	1689
2021 Q1	$524K	Buy	+5,543	New	+$659K	0.06%	542
2020 Q3	–	Sell	-5,489	Closed	-$355K	–	1450
2020 Q2	$355K	Buy	+5,489	New	+$317K	0.05%	609
2019 Q4	–	Sell	-10,053	Closed	-$378K	–	1407
2019 Q3	$378K	Buy	+10,053	New	+$438K	0.07%	553

Other funds holding TPTX

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

PAMS

Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

Dynamic Technology Lab's TPTX Position: Q4 2021 in Review

Dynamic Technology Lab sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q4 2021, closing a stake of 9,815 shares — an estimated $652K sold.

Dynamic Technology Lab first reported a position in TPTX in Q3 2019 and held it in 4 quarters. The position peaked at $652K in Q3 2021. 172 funds tracked by Wall St. Rank hold TPTX as of Q4 2021.

Dynamic Technology Lab reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
Dynamic Technology Lab sold 9,815 Turning Point Therapeutics, Inc. Common Stock shares in Q4 2021, an estimated $652K.
Dynamic Technology Lab first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q3 2019 and held it in 4 quarters.
Dynamic Technology Lab's Turning Point Therapeutics, Inc. Common Stock position peaked at $652K in Q3 2021.
172 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q4 2021.

Based on Dynamic Technology Lab's 13F filing for Q4 2021, filed 14 Feb 2022.